tiprankstipranks
Trending News
More News >
KalVista Pharmaceuticals (KALV)
NASDAQ:KALV
Advertisement

KalVista Pharmaceuticals (KALV) Similar Stocks

Compare
521 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
KalVista Pharmaceuticals
$13.59
$657.39M
7.18%
9 Buy
0 Hold
0 Sell
Strong Buy
Rocket Pharmaceuticals
$3.32
$365.79M
-82.62%
8 Buy
6 Hold
1 Sell
Moderate Buy
Dianthus Therapeutics
$24.24
$783.14M
-15.33%
10 Buy
0 Hold
0 Sell
Strong Buy
Replimune Group
$5.53
$443.36M
-44.64%
2 Buy
6 Hold
1 Sell
Hold
LENZ Therapeutics
$37.37
$1.10B
69.86%
7 Buy
0 Hold
0 Sell
Strong Buy
GH Research
$13.39
$830.56M
20.41%
8 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
KALV
KalVista Pharmaceuticals
13.59
0.70
5.43%
RCKT
Rocket Pharmaceuticals
3.32
-15.21
-82.08%
DNTH
Dianthus Therapeutics
24.24
-4.15
-14.62%
REPL
Replimune Group
5.53
-4.77
-46.31%
LENZ
LENZ Therapeutics
37.37
15.27
69.10%
GHRS
GH Research
13.63
2.63
23.91%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis